7 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
the Preventive Treatment ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Sepsis Treatment Overview #Management #EM #IM #PCC #Sepsis #Overview #BMJ
Sepsis Treatment ... Overview #Management #EM ... #IM #PCC #Sepsis ... #Overview #BMJ
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
EGPA) • Renal: (AKI ... nose deformity • Cardiac ... antibody, Anti-GBM ... (UPC) ratio • Cardiac ... diagnosis #management #treatment
Evolution of Purpura Fulminans - On physical examination, he had small purpura on his legs (Panel
Treatment with broad-spectrum ... Clinical #Derm #EM ... #IM #PurpuraFulminans ... Meningococcemia #NEJM
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
recommendations, treatments ... #medications #treatment ... Petersen EBM, Skov ... EL, Richardson IM ... (5):1821-1829. doi